2583 篇
1049 篇
239740 篇
3230 篇
7540 篇
2196 篇
2745 篇
529 篇
37448 篇
8995 篇
3112 篇
727 篇
2285 篇
1309 篇
447 篇
752 篇
1383 篇
2580 篇
2737 篇
3913 篇
全球视网膜药物市场报告(2025-2029年)
Global Retinal Drugs Market 2025-2029
Retinal drugs are the medications that are used in the treatment of retinal diseases. Anti-vascular endothelial growth factor (VEGF) agents and corticosteroids are the two major drug classes that are being used for the treatment of various retinal diseases such as wet age-related Macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME), diabetic retinopathy, and myopic choroidal neovascularization (mCNV). Among them, anti-VEGF agents are considered the gold standard for the treatment of various retinal diseases such as AMD, DME, and RVO.